high-specific-activity 131I-MIBG

Open Access
Efficacy and Safety of High-Specific-Activity ¹³¹I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Daniel A. Pryma, Bennett B. Chin, Richard B. Noto, Joseph S. Dillon, Stephanie Perkins, Lilja Solnes, Lale Kostakoglu, Aldo N. Serafini, Miguel H. Pampaloni, Jessica Jensen, Thomas Armor, Tess Lin, Theresa White, Nancy Stambler, Stuart Apfel, Vincent A. DiPippo, Syed Mahmood, Vivien Wong and Camilo Jimenez

Journal of Nuclear Medicine May 1, 2019, 60 (5) 623-630; DOI: https://doi.org/10.2967/jnumed.118.217463

Main menu